Analysts Have Conflicting Sentiments on These Technology Companies: ON Semiconductor (ON), ams AG (OtherAUKUF) and Privia Health Group (PRVA)

Analysts have been eager to weigh in on the Technology sector with new ratings on ON Semiconductor (ON – Research Report), ams AG (AUKUF – Research Report) and Privia Health Group (PRVA – Research Report).

ON Semiconductor (ON)

In a report released today, John Vinh from KeyBanc maintained a Buy rating on ON Semiconductor, with a price target of $72.00. The company’s shares closed last Tuesday at $65.45, close to its 52-week high of $66.79.

According to TipRanks.com, Vinh is a 5-star analyst with an average return of 23.1% and a 70.2% success rate. Vinh covers the Technology sector, focusing on stocks such as Lattice Semiconductor, Silicon Laboratories, and indie Semiconductor.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ON Semiconductor with a $62.95 average price target.

See the top stocks recommended by analysts >>

ams AG (AUKUF)

Morgan Stanley analyst Adam Wood maintained a Hold rating on ams AG today and set a price target of CHF20.50. The company’s shares closed last Tuesday at $18.39, close to its 52-week low of $17.01.

According to TipRanks.com, Wood is ranked #1842 out of 7752 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for ams AG with a $21.37 average price target.

Privia Health Group (PRVA)

In a report released today, Whit Mayo from Leerink Partners maintained a Buy rating on Privia Health Group, with a price target of $43.00. The company’s shares closed last Tuesday at $21.90, close to its 52-week low of $20.20.

According to TipRanks.com, Mayo is a 4-star analyst with an average return of 7.6% and a 54.1% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Oak Street Health, and Surgery Partners.

Currently, the analyst consensus on Privia Health Group is a Strong Buy with an average price target of $41.67.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ON:

• Analysts Offer Insights on Healthcare Companies: Omeros (OMER) and Recursion Pharmaceuticals (RXRX)
• Dave & Buster’s Posts Mixed Q3 Results; Shares Up
• EVgo: Partnerships to Drive Growth
• Wednesday’s Pre-Market: Here’s What You Need to Know Before the Market Opens
• Re/Max Holdings (RMAX) Gets a Hold Rating from J.P. Morgan